Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Wolff

Showing results (791-800 of 973) with videos related to

Pageof 98
Sort By:
Journal of Hematology & Oncology|May 30, 2015
HER2/neu-directed therapy for biliary tract cancerMilind Javle, Chaitanya Churi, HyunSeon C Kang, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 27, 2007
Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytesDavid B Rozema, David L Lewis, Darren H Wakefield, et al.
Annals of Surgery|June 27, 2007
Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinomaChandrajit P Raut, Jennifer F Tseng, Charlotte C Sun, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|April 9, 2021
Overexpression of CD73 in pancreatic ductal adenocarcinoma is associated with immunosuppressive tumor microenvironment and poor survivalJun Zhao, Luisa M Solis Soto, Hua Wang, et al.
International Journal of Radiation Oncology, Biology, Physics|May 26, 2009
Phase II trial of neoadjuvant bevacizumab, capecitabine, and radiotherapy for locally advanced rectal cancerChristopher H Crane, Cathy Eng, Barry W Feig, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|October 17, 2013
Morbidity and mortality after pancreaticoduodenectomy in patients with borderline resectable type C clinical classificationChing-Wei D Tzeng, Matthew H G Katz, Jason B Fleming, et al.
Oncotarget|April 21, 2017
FBXW7 missense mutation: a novel negative prognostic factor in metastatic colorectal adenocarcinomaKrittiya Korphaisarn, Van Karlyle Morris, Michael J Overman, et al.
Cancers|June 28, 2023
Comparative Analyses of the Clinicopathologic Features of Short-Term and Long-Term Survivors of Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and PancreatoduodenectomyTom Z Liang, Matthew H G Katz, Laura R Prakash, et al.
Molecular Cancer Research : MCR|August 17, 2017
Chemoradiotherapy Resistance in Colorectal Cancer Cells is Mediated by Wnt/β-catenin SignalingGeorg Emons, Melanie Spitzner, Sebastian Reineke, et al.
Journal of Neuro-Oncology|April 7, 2006
Treatment options in childhood pontine gliomasSabine Wagner, Monika Warmuth-Metz, Angela Emser, et al.
Pageof 98

Showing results (791-800 of 973) with videos related to

Sort By:
Pageof 98
Journal of Hematology & Oncology|May 30, 2015
HER2/neu-directed therapy for biliary tract cancerMilind Javle, Chaitanya Churi, HyunSeon C Kang, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 27, 2007
Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytesDavid B Rozema, David L Lewis, Darren H Wakefield, et al.
Annals of Surgery|June 27, 2007
Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinomaChandrajit P Raut, Jennifer F Tseng, Charlotte C Sun, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|April 9, 2021
Overexpression of CD73 in pancreatic ductal adenocarcinoma is associated with immunosuppressive tumor microenvironment and poor survivalJun Zhao, Luisa M Solis Soto, Hua Wang, et al.
International Journal of Radiation Oncology, Biology, Physics|May 26, 2009
Phase II trial of neoadjuvant bevacizumab, capecitabine, and radiotherapy for locally advanced rectal cancerChristopher H Crane, Cathy Eng, Barry W Feig, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|October 17, 2013
Morbidity and mortality after pancreaticoduodenectomy in patients with borderline resectable type C clinical classificationChing-Wei D Tzeng, Matthew H G Katz, Jason B Fleming, et al.
Oncotarget|April 21, 2017
FBXW7 missense mutation: a novel negative prognostic factor in metastatic colorectal adenocarcinomaKrittiya Korphaisarn, Van Karlyle Morris, Michael J Overman, et al.
Cancers|June 28, 2023
Comparative Analyses of the Clinicopathologic Features of Short-Term and Long-Term Survivors of Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and PancreatoduodenectomyTom Z Liang, Matthew H G Katz, Laura R Prakash, et al.
Molecular Cancer Research : MCR|August 17, 2017
Chemoradiotherapy Resistance in Colorectal Cancer Cells is Mediated by Wnt/β-catenin SignalingGeorg Emons, Melanie Spitzner, Sebastian Reineke, et al.
Journal of Neuro-Oncology|April 7, 2006
Treatment options in childhood pontine gliomasSabine Wagner, Monika Warmuth-Metz, Angela Emser, et al.
Pageof 98